Adherence to combined Lamivudine+Zidovudine versus individual components: A community-based retrospective medicaid claims analysis

By Legorreta A.   Yu A.   Chernicoff H.   Gilmore A.   Jordan J.   Rosenzweig J. C.  

AIDS Care, Vol. 17, Iss. 8, 2005-11 ,pp. : 938-948

Routledge Ltd

Access to resources Recommend Favorite

Higher Placental Anti-Inflammatory IL-10 Cytokine Expression in HIV-1 Infected Women Receiving Longer Zidovudine Prophylaxis Associated with Nevirapine

By  

Current HIV Research, Vol. 7, Iss. 2, 2009-03 ,pp. : 211-217

Bentham Science Publishers

Access to resources Recommend Favorite

Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz

By Cooper Vanessa   Moyle Graeme   Fisher Martin   Reilly Geraldine   Ewan Jacqueline   Liu Hui   Horne Rob  

AIDS Care, Vol. 23, Iss. 6, 2011-06 ,pp. : 705-713

Routledge Ltd

Access to resources Recommend Favorite

Quadruple Nucleos(t)ide Reverse Transcriptase Inhibitors-Only Regimen of Tenofovir Plus Zidovudine/Lamivudine/Abacavir in Heavily Pre-Treated HIV-1 Infected Patients: Salvage Therapy or Backbone Only?

By  

Current HIV Research, Vol. 7, Iss. 3, 2009-05 ,pp. : 320-326

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of a Low Cost Reverse Transcriptase Assay for Plasma HIV-1 Viral Load Monitoring

By  

Current HIV Research, Vol. 3, Iss. 2, 2005-04 ,pp. : 183-190

Bentham Science Publishers

Access to resources Recommend Favorite